Home > News > Nanogen Completes Acquisition of SynX Pharma Inc.
April 21st, 2004
Nanogen Completes Acquisition of SynX Pharma Inc.
Nanogen, Inc. and SynX Pharma Inc. announced today that Nanogen completed its acquisition of all of the common shares and debentures of SynX, pursuant to a plan of arrangement, in exchange for shares of Nanogen common stock. SynX is now a wholly-owned subsidiary of Nanogen.
Nanometrics Announces Upcoming Investor Events May 10th, 2016
ORIG3N Added to Companies Presenting at Harris & Harris Group's Annual Meeting, Tuesday June 7, 2016, the New York Genome Center April 27th, 2016
Aspen Aerogels to Present at the 28th Annual ROTH Conference March 14th, 2016
Harris & Harris Group Announces Formation of Co-Investment Fund for Accredited Investors March 9th, 2016
GLOBALFOUNDRIES to Expand Presence in China with 300mm Fab in Chongqing: Company plans new manufacturing facility and additional design capabilities to serve customers in China May 31st, 2016
Nanobiotix establishes promising preclinical proof-of-concept in Immuno Oncology May 31st, 2016
UK NANOSAFETY GROUP publishes 2nd Edition of guidance to support safe working with nanomaterials May 30th, 2016
Fast, stretchy circuits could yield new wave of wearable electronics May 30th, 2016